In addition to SET, miR-199b has been reported to regulate other important targets such as HEIS1, HIF1α or HER2 in medulloblastoma, hepatocellular carcinoma and breast cancers [23–25]. The gene discussed is ERBB2; the disease is hepatocellular carcinoma.